IL17A and systemic lupus erythematosus: Interestingly, when these mice are crossed on an IL-23p19-/- mouse line, they do not develop SLE, indicating that the development of an SLE phenotype through enhanced IFN type I production in these mice is dependent on the IL-17/Th17 pathway.